Suppr超能文献

黏液瘤病毒的锚蛋白重复序列宿主范围蛋白M-T5可激活Akt,并且在功能上可被细胞PIKE-A替代。

M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A.

作者信息

Werden Steven J, Barrett John W, Wang Gen, Stanford Marianne M, McFadden Grant

机构信息

Department of Microbiology and Immunology, University of Western Ontario and Robarts Research Institute, London, Ontario, Canada.

出版信息

J Virol. 2007 Mar;81(5):2340-8. doi: 10.1128/JVI.01310-06. Epub 2006 Dec 6.

Abstract

The myxoma virus (MV) ankyrin repeat, host range factor M-T5 has the ability to bind and activate cellular Akt, leading to permissive MV replication in a variety of diverse human cancer cell lines (G. Wang, J. W. Barrett, M. Stanford, S. J. Werden, J. B. Johnston, X. Gao, M. Sun, J. Q. Cheng, and G. McFadden, Proc. Natl. Acad. Sci. USA 103:4640-4645, 2006). The susceptibility of permissive human cancer cells to MV infection is directly correlated with the basal or induced levels of phosphorylated Akt. When M-T5 is deleted from MV, the knockout virus, vMyxT5KO, can no longer productively infect a subset of human cancer cells (designated type II) that exhibit little or no endogenous phosphorylated Akt. In searching for a host counterpart of M-T5, we noted sequence similarity of M-T5 to a recently identified ankyrin repeat cellular binding protein of Akt called PIKE-A. PIKE-A binds and activates the kinase activity of Akt in a GTP-dependent manner and promotes the invasiveness of human cancer cell lines. Here, we demonstrate that transfected PIKE-A is able to rescue the ability of vMyxT5KO to productively infect type II human cancer cells that were previously resistant to infection. Also, cancer cells that were completely nonpermissive for both wild-type and vMyxT5KO infection (called type III) were rendered fully permissive following ectopic expression of PIKE-A. We conclude that the MV M-T5 host range protein is functionally interchangeable with the host PIKE-A protein and that the activation of host Akt by either M-T5 or PIKE-A is critical for the permissiveness of human cancer cells for MV.

摘要

黏液瘤病毒(MV)锚蛋白重复序列宿主范围因子M-T5能够结合并激活细胞Akt,从而导致MV在多种不同的人类癌细胞系中实现许可性复制(G. Wang、J. W. Barrett、M. Stanford、S. J. Werden、J. B. Johnston、X. Gao、M. Sun、J. Q. Cheng和G. McFadden,《美国国家科学院院刊》103:4640 - 4645,2006年)。许可性人类癌细胞对MV感染的易感性与磷酸化Akt的基础水平或诱导水平直接相关。当从MV中删除M-T5时,敲除病毒vMyxT5KO就无法再有效感染一小部分几乎没有或没有内源性磷酸化Akt的人类癌细胞(称为II型)。在寻找M-T5的宿主对应物时,我们注意到M-T5与最近鉴定的一种名为PIKE-A的Akt锚蛋白重复序列细胞结合蛋白存在序列相似性。PIKE-A以GTP依赖的方式结合并激活Akt的激酶活性,并促进人类癌细胞系的侵袭性。在此,我们证明转染的PIKE-A能够挽救vMyxT5KO有效感染先前对感染有抗性的II型人类癌细胞的能力。此外,对野生型和vMyxT5KO感染都完全不许可的癌细胞(称为III型)在异位表达PIKE-A后变得完全许可。我们得出结论,MV M-T5宿主范围蛋白在功能上可与宿主PIKE-A蛋白互换,并且M-T5或PIKE-A对宿主Akt的激活对于人类癌细胞对MV的许可性至关重要。

相似文献

2
Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4640-5. doi: 10.1073/pnas.0509341103. Epub 2006 Mar 14.
3
The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus.
Biochim Biophys Acta. 2008 Jan;1784(1):228-37. doi: 10.1016/j.bbapap.2007.08.001. Epub 2007 Aug 14.
6
PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.
Proc Natl Acad Sci U S A. 2004 May 4;101(18):6993-8. doi: 10.1073/pnas.0400921101. Epub 2004 Apr 26.
10
PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion.
Oncogene. 2007 Jul 26;26(34):4918-27. doi: 10.1038/sj.onc.1210290. Epub 2007 Feb 12.

引用本文的文献

2
Diversity and structural-functional insights of alpha-solenoid proteins.
Protein Sci. 2024 Nov;33(11):e5189. doi: 10.1002/pro.5189.
3
Poxviral ANKR/F-box Proteins: Substrate Adapters for Ubiquitylation and More.
Pathogens. 2022 Aug 3;11(8):875. doi: 10.3390/pathogens11080875.
5
Poxvirus Interactions with the Host Ubiquitin System.
Pathogens. 2021 Aug 16;10(8):1034. doi: 10.3390/pathogens10081034.
7
Translational control during poxvirus infection.
Wiley Interdiscip Rev RNA. 2019 Mar;10(2):e1515. doi: 10.1002/wrna.1515. Epub 2018 Oct 31.
9
Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway.
Viruses. 2016 May 24;8(6):152. doi: 10.3390/v8060152.
10
Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.
J Virol. 2015 Aug;89(15):7625-35. doi: 10.1128/JVI.01027-15. Epub 2015 May 13.

本文引用的文献

1
Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4640-5. doi: 10.1073/pnas.0509341103. Epub 2006 Mar 14.
2
Poxvirus entry and membrane fusion.
Virology. 2006 Jan 5;344(1):48-54. doi: 10.1016/j.virol.2005.09.037.
3
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.
Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201.
4
Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings.
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16853-8. doi: 10.1073/pnas.0507365102. Epub 2005 Nov 1.
6
Poxvirus tropism.
Nat Rev Microbiol. 2005 Mar;3(3):201-13. doi: 10.1038/nrmicro1099.
7
PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus.
EMBO J. 2004 Oct 13;23(20):3995-4006. doi: 10.1038/sj.emboj.7600392. Epub 2004 Sep 23.
8
PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.
Proc Natl Acad Sci U S A. 2004 May 4;101(18):6993-8. doi: 10.1073/pnas.0400921101. Epub 2004 Apr 26.
9
The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival.
J Gen Virol. 2004 May;85(Pt 5):1065-1076. doi: 10.1099/vir.0.19771-0.
10
PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion.
J Biol Chem. 2004 Apr 16;279(16):16441-51. doi: 10.1074/jbc.M312175200. Epub 2004 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验